Nuance Biotech Inc announced that it has received $20,000,000 in its series B round of funding on June 28, 2019. The transaction was led new investor C-Bridge Capital Partners LLC and included participation from HBM Healthcare Investments AG (SWX:HBMN); a fund co-managed by new investors HBM Partners Ltd. and nebag ag (SWX:NBEN) for $2 million. As part of the transaction, Neo Zhang, managing director of the investor, has joined the board of the company.